checkAd

     412  0 Kommentare Nutra Pharma Announces Addition of Keith Gordon, DVM to the Company's Medical Advisory Board

    CORAL SPRINGS, FL--(Marketwired - Jan 20, 2015) - Nutra Pharma Corporation (OTC: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they have added Keith Gordon, DVM as their first Veterinarian to join the Company's Medical Advisory Board. The addition of Dr. Gordon comes just a few weeks after the successful launch of Nutra Pharma's newest product, Pet Pain-Away for the treatment of chronic pain in companion animals.

    "We are thrilled to announce the addition of Dr. Gordon to our Medical Advisory Board," commented Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "We began shipping Pet Pain-Away just a few weeks ago and have already received positive responses from hundreds of product users as well as several Veterinarians," he continued. "With the success that we are already seeing with Pet Pain-Away, it behooves us to have a Veterinarian of Dr. Gordon's caliber on our Advisory Board to help steer the future course of Nutra Pharma's animal health product line," he concluded.

    Dr. Keith Gordon has been practicing Veterinary Medicine for thirty years. For twenty three years, he owned his own practice, All Pets Animal Hospital in Staten Island, NY before merging with a newer state of the art facility, Bay St Animal Hospital where he currently practices. Dr. Gordon also started and runs a veterinary business called House Calls for Pets. He has always had an interest in treating arthritic animals and in 2009 was certified to perform Stem Cell Regenerative Medicine.

    "I am excited to join the Medical Advisory Board of Nutra Pharma and support their efforts with Pet Pain-Away," commented Dr. Keith Gordon. "This new product provides another mode of treatment for pets with chronic pain that have not responded well to other therapies such as narcotics, NSAIDS, or steroids; and seems to lack the side-effects associated with all of those other modalities," he continued. "I've already received results from the Pet Pain-Away in six patients. Two people used the word 'miracle' and all but one had significant improvement with their pain management. It's really exciting to have an alternative product to try to make our buddies more comfortable," he concluded.

    Seite 1 von 2




    Verfasst von Marketwired
    Nutra Pharma Announces Addition of Keith Gordon, DVM to the Company's Medical Advisory Board CORAL SPRINGS, FL--(Marketwired - Jan 20, 2015) - Nutra Pharma Corporation (OTC: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, …